December 15, 2023 Comments Off on New patent for Boehringer Ingelheim drug JARDIANCE Posted in: Patent Added Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from four suppliers. There are eight patents…
The post New patent for Boehringer Ingelheim drug JARDIANCE appe…
December 15, 2023 Comments Off on New patent for IBSA drug TIROSINT-SOL Posted in: Patent Added Annual Drug Patent Expirations for TIROSINT-SOL Tirosint-sol is a drug marketed by Ibsa and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for IBSA drug TIROSINT-SOL appeared first on Dr…